Error 404
Object not found
This object does not exist or is not publicly accessible at this URL. Check the URL of the object that you're looking for or contact the owner to enable Public access.
Learn how to enable Public Access
Geographic Coverage of Europe Renal Denervation Devices Industry
Europe Renal Denervation Devices Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 22% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Objective
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Market Snapshot
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restrains
- 3.3. Market Trends
- 3.4. Market Opportunities
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL analysis
- 4.3. BCG Analysis
- 4.3.1. Stars (High Growth, High Market Share)
- 4.3.2. Cash Cows (Low Growth, High Market Share)
- 4.3.3. Question Mark (High Growth, Low Market Share)
- 4.3.4. Dogs (Low Growth, Low Market Share)
- 4.4. Ansoff Matrix Analysis
- 4.5. Supply Chain Analysis
- 4.6. Regulatory Landscape
- 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
- 4.8. PMV Analyst Note
- 4.1. Porters Five Forces
- 5. Market Analysis, Insights and Forecast 2021-2033
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 5.1.1. Radiofrequency-based
- 5.1.2. Ultrasound-based
- 5.1.3. Micro-infusion-based
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. Germany
- 5.2.2. United Kingdom
- 5.2.3. France
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Technology
- 6. Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2021-2033
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 6.1.1. Radiofrequency-based
- 6.1.2. Ultrasound-based
- 6.1.3. Micro-infusion-based
- 6.1. Market Analysis, Insights and Forecast - by Technology
- 7. Germany Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 7.1.1. Radiofrequency-based
- 7.1.2. Ultrasound-based
- 7.1.3. Micro-infusion-based
- 7.1. Market Analysis, Insights and Forecast - by Technology
- 8. United Kingdom Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 8.1.1. Radiofrequency-based
- 8.1.2. Ultrasound-based
- 8.1.3. Micro-infusion-based
- 8.1. Market Analysis, Insights and Forecast - by Technology
- 9. France Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 9.1.1. Radiofrequency-based
- 9.1.2. Ultrasound-based
- 9.1.3. Micro-infusion-based
- 9.1. Market Analysis, Insights and Forecast - by Technology
- 10. Italy Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 10.1.1. Radiofrequency-based
- 10.1.2. Ultrasound-based
- 10.1.3. Micro-infusion-based
- 10.1. Market Analysis, Insights and Forecast - by Technology
- 11. Spain Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Technology
- 11.1.1. Radiofrequency-based
- 11.1.2. Ultrasound-based
- 11.1.3. Micro-infusion-based
- 11.1. Market Analysis, Insights and Forecast - by Technology
- 12. Rest of Europe Europe Renal Denervation Devices Industry Analysis, Insights and Forecast, 2020-2032
- 12.1. Market Analysis, Insights and Forecast - by Technology
- 12.1.1. Radiofrequency-based
- 12.1.2. Ultrasound-based
- 12.1.3. Micro-infusion-based
- 12.1. Market Analysis, Insights and Forecast - by Technology
- 13. Competitive Analysis
- 13.1. Company Profiles
- 13.1.1 Medtronic PLC
- 13.1.1.1. Company Overview
- 13.1.1.2. Products
- 13.1.1.3. Company Financials
- 13.1.1.4. SWOT Analysis
- 13.1.2 Symple Surgical
- 13.1.2.1. Company Overview
- 13.1.2.2. Products
- 13.1.2.3. Company Financials
- 13.1.2.4. SWOT Analysis
- 13.1.3 ReCor Medical Inc
- 13.1.3.1. Company Overview
- 13.1.3.2. Products
- 13.1.3.3. Company Financials
- 13.1.3.4. SWOT Analysis
- 13.1.4 Terumo Corporation
- 13.1.4.1. Company Overview
- 13.1.4.2. Products
- 13.1.4.3. Company Financials
- 13.1.4.4. SWOT Analysis
- 13.1.5 Boston Scientific Corporation
- 13.1.5.1. Company Overview
- 13.1.5.2. Products
- 13.1.5.3. Company Financials
- 13.1.5.4. SWOT Analysis
- 13.1.6 Mercator MedSystems
- 13.1.6.1. Company Overview
- 13.1.6.2. Products
- 13.1.6.3. Company Financials
- 13.1.6.4. SWOT Analysis
- 13.1.7 Abbott (St Jude Medical Inc )
- 13.1.7.1. Company Overview
- 13.1.7.2. Products
- 13.1.7.3. Company Financials
- 13.1.7.4. SWOT Analysis
- 13.1.8 Cordis
- 13.1.8.1. Company Overview
- 13.1.8.2. Products
- 13.1.8.3. Company Financials
- 13.1.8.4. SWOT Analysis
- 13.1.1 Medtronic PLC
- 13.2. Market Entropy
- 13.2.1 Company's Key Areas Served
- 13.2.2 Recent Developments
- 13.3. Company Market Share Analysis 2025
- 13.3.1 Top 5 Companies Market Share Analysis
- 13.3.2 Top 3 Companies Market Share Analysis
- 13.4. List of Potential Customers
- 14. Research Methodology
List of Figures
- Figure 1: Europe Renal Denervation Devices Industry Revenue Breakdown (million, %) by Product 2025 & 2033
- Figure 2: Europe Renal Denervation Devices Industry Share (%) by Company 2025
List of Tables
- Table 1: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 2: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 3: Europe Renal Denervation Devices Industry Revenue million Forecast, by Region 2020 & 2033
- Table 4: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Region 2020 & 2033
- Table 5: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 6: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 7: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 8: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
- Table 9: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 10: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 11: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 12: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
- Table 13: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 14: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 15: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 16: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
- Table 17: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 18: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 19: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 20: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
- Table 21: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 22: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 23: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 24: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
- Table 25: Europe Renal Denervation Devices Industry Revenue million Forecast, by Technology 2020 & 2033
- Table 26: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Technology 2020 & 2033
- Table 27: Europe Renal Denervation Devices Industry Revenue million Forecast, by Country 2020 & 2033
- Table 28: Europe Renal Denervation Devices Industry Volume K Units Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Renal Denervation Devices Industry?
The projected CAGR is approximately 22%.
2. Which companies are prominent players in the Europe Renal Denervation Devices Industry?
Key companies in the market include Medtronic PLC, Symple Surgical, ReCor Medical Inc, Terumo Corporation, Boston Scientific Corporation, Mercator MedSystems, Abbott (St Jude Medical Inc ), Cordis.
3. What are the main segments of the Europe Renal Denervation Devices Industry?
The market segments include Technology.
4. Can you provide details about the market size?
The market size is estimated to be USD 47.6 million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Hypertension; Long Lasting Effect of the Procedure.
6. What are the notable trends driving market growth?
The Ultrasound-based Segment is Expected to Witness Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Painful Procedure; Stringent Approval Process for Renal Denervation Devices and Reimbursement Systems.
8. Can you provide examples of recent developments in the market?
In November 2022, Medtronic PLC, the Ireland-headquartered medical device company, submitted the final module of the renal denervation Symplicity Spyral Premarket Approval (PMA) package to the US FDA for review and approval.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K Units.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Renal Denervation Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Renal Denervation Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Renal Denervation Devices Industry?
To stay informed about further developments, trends, and reports in the Europe Renal Denervation Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence



